SCHEMBL4915437

SCHEMBL4915437

CC(C)(C)OC(=O)Cn1cccc1C(=O)O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.43
KMT2A Q03164 2/20 0.43
MEN1 O00255 1/20 0.43
LMNA P02545 1/20 0.43
MAPT P10636 1/20 0.43
ALOX12 P18054 1/20 0.43
RECQL P46063 1/20 0.43
KDM4E B2RXH2 1/20 0.40
HDAC6 Q9UBN7 2/20 0.39
POLB P06746 1/20 0.37
APEX1 P27695 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
PLA2G10 O15496 1/20 0.36
PLA2G5 P39877 1/20 0.36
FPR2 P25090 1/20 0.36
MTNR1A P48039 1/20 0.36
MTNR1B P49286 1/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25391946 0.85 ALDH1A1 (0.35) ALDH1A1KMT2AMEN1LMNAMAPT
SCHEMBL4610205 0.85 GAA (0.39) ALDH1A1KMT2AMEN1LMNAMAPT
SCHEMBL25395276 0.82 CNR2 (0.37) ALDH1A1KMT2AMEN1LMNAMAPT
SCHEMBL1664069 0.82 MEN1 (0.46) ALDH1A1KMT2AMEN1LMNAMAPT
SCHEMBL25394242 0.81 HDAC8 (0.39) ALDH1A1KMT2AMEN1LMNAMAPT
SCHEMBL8266056 0.81 KDM4E (0.42) ALDH1A1KMT2AMAPTKDM4EHDAC6
SCHEMBL4474821 0.79 KMT2A (0.43) ALDH1A1KMT2AMEN1KDM4EHDAC6
SCHEMBL15030294 0.77 KDM4E (0.42) ALDH1A1KMT2AMAPTKDM4EHDAC6
SCHEMBL24709934 0.77 ALDH1A1 (0.40) ALDH1A1KMT2AMEN1ALOX12KDM4E
SCHEMBL17962565 0.76 ALDH1A1 (0.50) ALDH1A1KMT2AMEN1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112279848-A Pan-JAKs inhibitor and application thereof 四川海思科制药有限公司 2021-01-29 CN disclosed
US-20080146814-A1 Process for producing N-protected boryl compounds BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) 2008-06-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080146814-A1 Process for producing N-protected boryl compounds PBK, NME2, ZC3HAV1 ALDH1A1 4082/4885KMT2A 2651/4885MEN1 741/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.